A Pharmacometric Model to Predict Chemotherapy-Induced Myelosuppression and Associated Risk Factors in Non-Small Cell Lung Cancer.

Park, Kyemyung; Kim, Yukyung; Son, Mijeong; Chae, Dongwoo; Park, Kyungsoo

Park, Kyemyung; Kim, Yukyung; Son, Mijeong; Chae, Dongwoo; Park, Kyungsoo.

Afiliación

Park K; Department of Pharmacology, Yonsei University College of Medicine, Seoul 03722, Korea.
Kim Y; Brain Korea 21 Plus Project for Medical Science, Yonsei University, Seoul 03722, Korea.
Son M; Department of Pharmacology, Yonsei University College of Medicine, Seoul 03722, Korea.
Chae D; Department of Pharmacology, Yonsei University College of Medicine, Seoul 03722, Korea.
Park K; Department of Pharmacology, Yonsei University College of Medicine, Seoul 03722, Korea.

Pharmaceutics ; 14(5)2022 Apr 22.

Article en En | MEDLINE | ID: mdl-35631500

Palabras clave

K-PD model; R Shiny; chemotherapy; cisplatin; myelosuppression; neutropenia; non-small cell lung cancer; paclitaxel; pharmacokinetic and pharmacodynamic modeling; transit compartments

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pharmaceutics Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google